Google Alert - Business

	Business Daily update ⋅ September 13, 2022
	NEWS
	Harvard Business Review How to Use Digital Health Data to Improve Outcomes Harvard Business Review Here's an all-too-common scenario: June, aged 67, is in the emergency department with abdominal pain and rectal bleeding. Tests reveal inoperable colon cancer that's probably been developing for years. After ... Flag as irrelevant
	NPR How ESG investing got tangled up in America's culture wars NPR Anti-ESG Republicans say big financial firms are abusing their power to advance a liberal agenda on issues like diversity, social justice and, especially, climate change. Many experts disagree, saying Republicans are distorting ... Flag as irrelevant
	The Washington Post Blue Origin rocket suffers problem during uncrewed launch The Washington Post Blue Origin's New Shepard rocket suffered a serious problem after lifting off Monday morning, forcing the vehicle's emergency abort system to jettison the capsule away from the booster. No people were on board — only science experiments — in what was ... Flag as irrelevant
	Politico High energy prices ahead Politico Delivered every Monday by 10 a.m., New York & New Jersey Energy is your guide to the week's top energy news and policy in Albany and Trenton. Flag as irrelevant
	Business Wire UnitedHealthcare fires back, sues Envision for allegedly exaggerating patient claims Healthcare Dive UnitedHealthcare, one of the nation's largest insurers, filed a lawsuit against Envision Healthcare alleging it overpaid the physician staffing firm millions of dollars after Envision exaggerated the complexity of illness and care provided to thousands ... Flag as irrelevant
	www.oncnursingnews.com/ HRQOL Analysis of KEYNOTE-522 Supports Pembrolizumab Treatment for Triple-Negative Breast Cancer www.oncnursingnews.com/ Patients who received pembrolizumab (Keytruda) to treat early-stage, triple-negative breast cancer (TNBC) reported similar scores across global health score (GHS), function, and breast symptom domains, compared with patients who received placebo, ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback